Home › Kleincellige longkanker › Texas › Dallas
Kleincellige longkanker klinische studies in Dallas, TX
13 studies voor Kleincellige longkanker zoeken deelnemers op locaties in en rond Dallas (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- UT Southwest Simmons Cancer Center, Dallas
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- UT Southwestern, Dallas
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
RekruterenFase 2/3
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- Texas Oncology - DFW, Dallas
- en nog 2
DESTINY-PANTUMOUR04
RekruterenObservatieonderzoek
- Research Site, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruterenFase 1/2
- Baylor, Scott and White Research Institute, Dallas
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
RekruterenFase 3
- University of Texas Southwestern Medical Center/Clinical Research Department, Dallas
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
RekruterenFase 1/2
- Avenzo Therapeutics Recruiting Site, Dallas
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
RekruterenFase 1/2
- Texas Oncology - DFW, Dallas
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
RekruterenFase 1
- UT Southwestern Medical Center, Dallas
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
RekruterenFase 2
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern Medical Center, Dallas
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- NEXT Oncology - Dallas, Dallas
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Mary Crowley Cancer Research, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- Research Site 120, Dallas
Kleincellige longkanker studies in andere steden
- Houston, TX26 studies
- Arlington, VA23 studies
- Boston, MA21 studies
- New York City, NY21 studies
- Nashville, TN20 studies
- Los Angeles, CA20 studies
- Orlando, FL15 studies
- St. Louis, MO13 studies
- Cleveland, OH13 studies
- Detroit, MI12 studies
- Chicago, IL12 studies
- Washington, DC12 studies
Andere studies in Dallas
- Borstkanker55 studies
- Niet-kleincellige longkanker52 studies
- Metastatische kanker42 studies
- Hartfalen42 studies
- Kanker (alle vormen)37 studies
- Prostaatkanker36 studies
- Colorectale kanker33 studies
- Obesitas30 studies
- Eierstokkanker28 studies
- Blasenkanker27 studies
- Longkanker27 studies
- Endometriumkanker24 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.